Found vs Novi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent research·How we rank →

Visit Found - $129/mo→or find your match

Novi beats Found overall, scoring 7.8/10 vs 7.3/10. Found is more affordable at $129/mo vs $133/mo. Choose Found for insured patients who want their glp-1 coverage checked and t. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side look at Found and Novi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Found

#36 of 53

7.3/10

Science-backed weight management platform combining GLP-1 medications with behavioral health coaching and support.

Visit Found

Higher Rated

Novi

#12 of 53

7.8/10

Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.

Visit Novi

Feature	Found	Novi
Our Score	7.3/10	7.8/10
Starting Price	$129/mo	$133/mo
Medication Type	Both	Compounded
Insurance Accepted	Yes	No
Best For	Insured patients who want their GLP-1 coverage checked and their copay minimized	Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer
Watch out for	Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying	Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
Ranking	#36	#12
Get started	Visit Found	Visit Novi

Pros & Cons Compared

Found

Pros

+Active insurance coordination, Found contacts your insurer and reports which GLP-1s are covered, prior auth requirements, and estimated copay
+10+ medication options including both compounded and brand-name (Wegovy, Zepbound, Wegovy pill), the widest formulary of any platform
+Typical insured copay of ~$30/mo for most members, dramatically lower than cash-pay alternatives
+Most members start treatment within one week of completing the health questionnaire

Cons

−Costs vary by insurance status and medication choice rather than one flat rate; run Found's coverage check first to see your exact copay before paying
−The insurance navigation process adds steps compared to simple cash-pay platforms; the payoff is the ~$30 typical copay
−Compounded medication availability may shift with FDA enforcement changes; the 10+ medication formulary lets your clinician move you to a brand-name option if it does

Novi

Pros

+Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
+Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
+Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
+Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
+Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
+100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal

Cons

−Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
−Founding year, headquarters city, and corporate ownership are not publicly disclosed
−Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
−Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
−Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
−Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout

Our Verdict

Novi edges out Found with a score of 7.8/10 vs 7.3/10. If budget is your priority, Found starts at $129/mo compared to Novi's $133/mo. Found accepts insurance, which can significantly reduce your out-of-pocket costs. Found offers both brand-name and compounded medications, giving you more flexibility. Choose Found if you want: insured patients who want their glp-1 coverage checked and their copay minimized. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither Found nor Novi feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Visit TrimRx→Read our full TrimRx review